ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 1000

$911K Total Retail Price of All Prescriptions

Rank: 72 out of 1000

670 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 670 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

32% of this provider’s 670 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 17,080 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,495 963 S3 1 1
PRAVASTATIN SODIUM 1,100 870 2 12
LISINOPRIL 1,018 751 3 5
AMLODIPINE BESYLATE 1,000 753 4 6
OMEPRAZOLE 976 769 5 2
LEVOTHYROXINE SODIUM 763 599 6 4
SIMVASTATIN 625 494 7 3
METOPROLOL SUCCINATE 560 462 8 21
FUROSEMIDE 551 431 9 7
ATORVASTATIN CALCIUM 543 459 10 18
LOSARTAN POTASSIUM 528 424 11 25
MELOXICAM 467 342 12 14
POTASSIUM CHLORIDE 365 274 13 10
GLIMEPIRIDE 347 307 14 34
METFORMIN HCL ER 286 197 15 44
ZOLPIDEM TARTRATE 274 204 16 16
GABAPENTIN 268 210 17 11
METOPROLOL TARTRATE 254 214 18 19
CITALOPRAM HBR 252 178 19 17
LOVASTATIN 247 208 20 41
TAMSULOSIN HCL 243 215 21 33
PANTOPRAZOLE SODIUM 236 182 22 28
CLONIDINE HCL 220 160 23 27
RANITIDINE HCL 176 119 24 37
PAROXETINE HCL 173 115 25 63
DONEPEZIL HCL 172 170 26 32
LANSOPRAZOLE 172 127 26 190
CARVEDILOL 168 145 28 15
CRESTOR 166 136 29 30
LANTUS SOLOSTAR 157 107 30 120
NEXIUM 155 133 31 23
LOSARTAN-HYDROCHLOROTHIAZIDE 147 121 32 38
SPIRIVA 142 114 33 64
TRAZODONE HCL 133 96 34 29
CEFUROXIME 128 88 35 133
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 89 36 20
ALLOPURINOL 123 78 37 31
ALENDRONATE SODIUM 122 111 38 57
TRAMADOL HCL 121 82 39 13
METFORMIN HCL 120 79 40 8
CLOPIDOGREL 119 105 41 35
CYMBALTA 118 69 42 53
ATENOLOL 118 74 42 24
HYDROCHLOROTHIAZIDE 118 90 42 9
PROAIR HFA 112 57 45 50
PREDNISONE 109 75 46 42
WARFARIN SODIUM 108 101 47 22
AMLODIPINE BESYLATE-BENAZEPRIL 107 72 48 59
ESTRADIOL 106 92 R 49 114
NAPROXEN 104 80 50 81
FENOFIBRATE 95 62 51 55
LYRICA 93 53 52 47
SYNTHROID 85 69 53 91
TRIAMTERENE-HCTZ 85 83 53 48
PLAVIX 84 73 55 49
DOXEPIN HCL 82 59 56 176
NIFEDIPINE ER 80 73 57 130
AZITHROMYCIN 80 60 57 36
MIRTAZAPINE 80 64 57 56
TAZTIA XT 80 80 10 57 386
KLOR-CON M20 80 73 57 66
LEVEMIR FLEXPEN 79 61 62 205
FLUOXETINE HCL 79 40 62 51
FLUTICASONE PROPIONATE 78 55 64 40
VENTOLIN HFA 78 55 64 83
NAMENDA 76 76 66 43
PROMETHAZINE HCL 76 55 R 66 54
EVISTA 74 74 68 168
CYCLOBENZAPRINE HCL 72 13 R 69 39
METOCLOPRAMIDE HCL 68 59 70 99
SPIRONOLACTONE 68 53 70 78
BISOPROLOL-HYDROCHLOROTHIAZIDE 67 57 72 101
METHOCARBAMOL 66 21 R 73 79
VENLAFAXINE HCL ER 65 48 74 124
OXYBUTYNIN CHLORIDE ER 64 64 75 157
TRICOR 64 42 75 141
TRAMADOL HCL-ACETAMINOPHEN 64 60 75 151
DILTIAZEM 24HR CD 64 36 75 136
BENAZEPRIL HCL 63 50 79 61
ADVAIR DISKUS 62 27 80 65
CARISOPRODOL 62 39 R 80 72
DIGOXIN 62 62 80 52
CELEBREX 59 42 83 98
LANTUS 59 40 83 68
INSULIN SYRINGE 58 34 85 93
SERTRALINE HCL 57 38 86 26
CARBIDOPA-LEVODOPA 55 55 87 116
AMITRIPTYLINE HCL 54 19 R 88 45
PEN NEEDLE 54 32 88 165
FINASTERIDE 51 51 90 177
CILOSTAZOL 51 39 90 227
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.